Rx bonus for EU mail order pharmacies confirmed by German Supreme Court ruling.
|
EQS-News: Redcare Pharmacy N.V.
/ Key word(s): Legal Matter
Rx bonus for EU mail order pharmacies confirmed by German Supreme Court ruling.
Sevenum, the Netherlands. 17 July 2025 – Today, the German Supreme Court (Bundesgerichtshof – BGH) affirmed the European Court of Justice (ECJ) ruling in lawsuit I ZR 74/24: Online pharmacies based in the EU are not bound by the German fixed prices for prescription medicines. The BGH therefore confirms the ECJ case law from 2016 and strengthens fair competition in the European Single Market. The decision is a milestone for the supply of medicines in Germany. The BGH explicitly recognises that EU online pharmacies make a relevant contribution to nationwide supplies – both in urban and rural areas. "The ruling provides legal clarity. The benefits of the European Single Market also apply to the healthcare sector. Patients in Germany can rest assured that they will continue to receive safe care in the future - with freedom of choice when purchasing their medication by mail order. The BGH has thus focused on patients' rights: online pharmacies and bonus models are strengthened - for fair prices and modern pharmaceutical care throughout Germany”, says Olaf Heinrich, CEO of Redcare Pharmacy. The subject of the proceedings was a bonus model that granted German customers price reductions when redeeming prescriptions. The BGH rejected the complaint of a German pharmacists' association and clarified that such bonuses are legally permissible. A ban on bonuses is only justified if it would jeopardise the nationwide supply of medicines. The plaintiffs were unable to provide this evidence. The BGH ruling underlines the importance of freedom of competition and consumer interests in the European pharmaceutical market. “For our customers, this means one thing above all – they retain the choice. And customers rely on us to combine modern digital services with pharmaceutical quality and fair prices”, adds Olaf Heinrich.
___ Investor Relations Contact: Monica Ambrosi
Press Contact: Sven Schirmer
___ About Redcare Pharmacy. Originally founded in 2001, Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland. Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven. As the one-stop pharmacy of the future, Redcare Pharmacy offers over 13 million active customers a wide range of more than 250,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management. Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. As of 19 June 2023, the company is a member of the MDAX selection index.
17.07.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2171204 |
| End of News | EQS News Service |
|
|
2171204 17.07.2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.